ImThera has developed a proprietary therapeutic solution that promises an exciting, new era in sleep apnea treatment.
ImThera’s innovative Targeted Hypoglossal Neurostimulation (THN) Sleep Therapy delivers neurostimulation to the tongue during sleep. Using a multi-contact electrode and a programmable pulse generator, the system delivers muscle tone to key tongue muscles, effectively controlling upper airway flow and reducing or eliminating sleep apnea.
To help OSA patients who cannot comply with other therapies ImThera has developed the aura6000™ system and the THN Sleep Therapy method. The system does not require additional sensors or logic to detect the onset of Apnea or related events. It operates by targeting certain areas of the Hypooglossal nerve during sleep and stimulates multiple muscles of the tongue. The aura6000™ system effectively increases upper airway opening during sleep, disarming sleep apnea’s primary mechanism and restoring normal, restful sleep.